Literature DB >> 21491099

Serotonin toxicity: a short review of the literature and two case reports involving citalopram.

G Talarico1, G Tosto, S Pietracupa, E Piacentini, M Canevelli, G L Lenzi, G Bruno.   

Abstract

The serotonin toxicity (ST) is a potentially life-threatening adverse drug reaction results from therapeutic drug use, intentional self-poisoning, or inadvertent interactions between drugs. ST can be caused by a single or a combination of drugs with serotonergic activity due to excessive serotonergic agonism on central nervous system and peripheral serotonergic receptors (monoamine oxidase inhibitors, tricyclic antidepressants, SSRIs, opiate analgesics, over-the-counter cough medicines, antibiotics, weight-reduction agents, antiemetics, antimigraine agents, drugs of abuse, H2-antagonist and herbal products). The serotonin toxicity is often described as a clinical triad of mental-status changes (agitation and excitement with confusion), autonomic hyperactivity (diaphoresis, fever, tachycardia, and tachypnea), neuromuscular abnormalities (tremor, clonus, myoclonus, and hyperreflexia) and, in the advanced stage, spasticity; not all of these findings are consistently present. In this article, we describe two cases of ST due to interaction between Citalopram and two CYP2D6 inhibitors: Cimetidine and Topiramate and their clinical resolution after treatment discontinuation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21491099     DOI: 10.1007/s10072-011-0546-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  12 in total

Review 1.  Serotonin syndrome: a brief review.

Authors:  Philippe Birmes; Dominique Coppin; Laurent Schmitt; Dominique Lauque
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

Review 2.  The serotonin syndrome.

Authors:  H Sternbach
Journal:  Am J Psychiatry       Date:  1991-06       Impact factor: 18.112

Review 3.  The serotonin syndrome.

Authors:  Edward W Boyer; Michael Shannon
Journal:  N Engl J Med       Date:  2005-03-17       Impact factor: 91.245

4.  Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death.

Authors:  S S Kline; L S Mauro; D M Scala-Barnett; D Zick
Journal:  Clin Pharm       Date:  1989-07

5.  Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects.

Authors:  L L von Moltke; D J Greenblatt; J M Grassi; B W Granda; K Venkatakrishnan; S X Duan; S M Fogelman; J S Harmatz; R I Shader
Journal:  Biol Psychiatry       Date:  1999-09-15       Impact factor: 13.382

6.  An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria.

Authors:  J W Radomski; S M Dursun; M A Reveley; S P Kutcher
Journal:  Med Hypotheses       Date:  2000-09       Impact factor: 1.538

Review 7.  Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram.

Authors:  K Brøsen; C A Naranjo
Journal:  Eur Neuropsychopharmacol       Date:  2001-08       Impact factor: 4.600

Review 8.  Serotonin syndrome. Presentation of 2 cases and review of the literature.

Authors:  P J Mason; V A Morris; T J Balcezak
Journal:  Medicine (Baltimore)       Date:  2000-07       Impact factor: 1.889

Review 9.  The neuroleptic malignant and serotonin syndromes.

Authors:  J R Carbone
Journal:  Emerg Med Clin North Am       Date:  2000-05       Impact factor: 2.264

Review 10.  Serotonin syndrome and other serotonergic disorders.

Authors:  Rasih Atilla Ener; Sharon B Meglathery; William A Van Decker; Rollin M Gallagher
Journal:  Pain Med       Date:  2003-03       Impact factor: 3.750

View more
  7 in total

1.  Fatal intoxication with antidepressants: a case with many culprits.

Authors:  Antonis Goulas; Nikolaos Raikos; Diamantis Krokos; Orthodoxia Mastrogianni; Amvrosios Orphanidis; Konstantinos Zisopoulos; Androniki Tsepa
Journal:  Forensic Sci Med Pathol       Date:  2018-02-27       Impact factor: 2.007

Review 2.  [Drug interactions in pain therapy].

Authors:  K M J Syhr; B G Oertel; G Geisslinger
Journal:  Schmerz       Date:  2015-12       Impact factor: 1.107

3.  Case Reports Describing Amantadine Intoxication in a Rehabilitation Hospital.

Authors:  Kenjiro Kunieda; Takashi Shigematsu; Ichiro Fujishima
Journal:  Prog Rehabil Med       Date:  2017-12-27

Review 4.  Pharmacological potential of biogenic amine-polyamine interactions beyond neurotransmission.

Authors:  F Sánchez-Jiménez; M V Ruiz-Pérez; J L Urdiales; M A Medina
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

Review 5.  MDMA to Treat PTSD in Adults.

Authors:  Dustin Latimer; Michael D Stocker; Kia Sayers; Jackson Green; Adam M Kaye; Alaa Abd-Elsayed; Elyse M Cornett; Alan D Kaye; Giustino Varrassi; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2021-06-01

6.  Myoclonus in renal failure: Two cases of gabapentin toxicity.

Authors:  Kenneth R Kaufman; Amay Parikh; Lili Chan; Mary Bridgeman; Milisha Shah
Journal:  Epilepsy Behav Case Rep       Date:  2013-12-29

Review 7.  Spasticity in multiple sclerosis and role of glatiramer acetate treatment.

Authors:  Jose Eustasio Meca-Lallana; Rocío Hernández-Clares; Ester Carreón-Guarnizo
Journal:  Brain Behav       Date:  2015-07-14       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.